Slide 1
ACRO Releases Diversity & Inclusion Principles Statement

Created collaboratively by committee members, the Principles Statement is comprised of four key principles and associated actions that are vital to the work of ensuring all trials are diverse, inclusive, and equitable.

Slide Image
Slide 2
Keep Our Foot on the Gas for Clinical Trial Diversity

ACRO Chair and Executive Industry Advisor at Medidata, Jackie Kent, BS, authored an Op-Ed for MedPage Today on how broader representation can help address health disparities and improve patient outcomes.

Slide Image
Slide 2
ACRO & TransCelerate Issue Joint Statement on Considerations while Developing CSRs

Our member companies have faced widespread clinical trial disruptions
in the past few years - from the global pandemic, to the war in Ukraine.
We developed a recommendation for how sponsors and CROs should
report study disruptions in a Clinical Study Report (CSR).

Slide Image


Read about ACRO’s initiatives, COVID-19 efforts, and more.

Member Innovation Hub

Take a look at how our members are innovating in top focus areas.


Get ACRO’s newsletter to stay informed about our work and the industry.

    News and Comments


    ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)

    September 12, 2022

    Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…

    Press Releases

    ACRO Releases Diversity and Inclusion Principles Statement in Support of More Diverse Clinical Trials

    August 25, 2022

    WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to…


    OPINION: Keep Our Foot on the Gas for Clinical Trial Diversity

    August 8, 2022

    The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…

    Press Releases

    ACRO Marks 20th Anniversary – And Welcomes New Member

    April 1, 2022

    Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…

    Press Releases

    2022 Officers and New Member Announcement

    January 21, 2022

    Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…


    OPINION: Clinical Trials in the Spotlight: How to Solidify the Progress Made

    November 30, 2021

    The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…

    US Regulatory Policy

    Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »

    European Advocacy

    ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »

    CRO Forum

    ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »

    Clinical Research Roundtables

    In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »

    Data Protection & Privacy

    ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »

    Join ACRO and Add Your Voice

    We help create a global regulatory and business environment
    where ACRO members succeed

    ACRO Members